Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Nature Genetics, 2024

Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance

Wang Q., Hasegawa T., Namkoong H. et al.

Nature Medicine, 2024

Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity

Huang Y., Sulek K., Stinson S. et al.

Pediatric Research, 2024

Neurofilament light chain associates with IVH and ROP in extremely preterm infants

Sjöbom U., Öhrfelt A., Pivodic A. et al.

British Journal of Haematology, 2024

Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia

Jiang Y., Li J., Huang J. et al.

iScience, 2024

Pembrolizumab followed by irreversible electroporation of a liver metastasis in pancreatic cancer patients

Flak R., Kofod-Olsen E., Sølvsten N. et al.

Advanced Science, 2024

Extracellular Vesicles Derived from Ligament Tissue Transport Interleukin‐17A to Mediate Ligament‐To‐Bone Crosstalk in Ankylosing Spondylitis

Wang K., Lu J., Song C. et al.

Experimental Dermatology, 2024

Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses

Peeva E., Yamaguchi Y., Ye Z. et al.

Atherosclerosis, 2024

Relationship of proteins and subclinical cardiovascular traits in the population-based LIFE-Adult study

Garcia T., Petrera A., Hauck S. et al.

Clinical Immunology, 2024

Insights into the multifaceted role of interleukin-37 on human immune cell regulation

Teufel L., Matzaraki V., Folkman L. et al.

mBio, 2024

SARS-CoV-2 infection induces hyaluronan production in vitro and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort study

Hellman U., Rosendal E., Lehrstrand J. et al.

Healthcare, 2024

The Mediating Roles of Lung Function Traits and Inflammatory Factors on the Associations between Measures of Obesity and Risk of Lower Respiratory Tract Infections: A Mendelian Randomization Study

Ma X., Zhu P., Yang Q. et al.

Scientific Reports, 2024

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes

Rabin A., Bello E., Kumar S. et al.

The Journal of Pediatrics, 2024

Disruption of the Circulating Proteome in Neonates Receiving Extracorporeal Membrane Oxygenation Following Congenital Heart Disease Surgery: A Nested Case-Control Study

Thomson L., Niemiec S., Mancuso C. et al.

International Journal of Molecular Sciences, 2024

Regenerating Family Member 3 Alpha Is Predictive of Mortality Following Emergent Large Vessel Occlusion

Sands M., McLouth C., Frank J. et al.

Biomolecules, 2024

Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients

McLarnon T., McDaid D., Lynch S. et al.

Environmental Advances, 2024

Per-and polyfluoroalkyl substances and disrupted sleep: mediating roles of proteins

Li S., Goodrich J., Chen J. et al.

Cardiovascular Research, 2024

Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

Tubben A., Markousis-Mavrogenis G., Meems L. et al.

Scientific Reports, 2024

Proteomic Mendelian randomization to identify protein biomarkers of telomere length

Zhao J., Yang K., Lu Y. et al.

Alzheimer's & Dementia, 2024

Inflammatory protein associations with brain MRI measures: Framingham Offspring Cohort

Chen J., Ragab A., Doyle M. et al.

Dermatology and Therapy, 2024

Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial

Catlett I., Gao L., Hu Y. et al.

4555 publications